Publications
115 publications
Funding
12 grantsView NIH portfolio on RePORTER ↗
Active
5 grants- MPIDeterminants of TB Control, Relapse, and ReinfectionNIAID · 2026–2031 · via NIH RePORTERP01AI202868-06
- MPIHematopoietic stem cell encoded anti-tumor immunity: mechanisms and functionNCI · 2026–2031 · via NIH RePORTER
- PINovel pathway of DNA inter-strand crosslink repair in mycobacteriaNIAID · 2005–2031 · via NIH RePORTER
- MPIChalkophore mediated respiratory oxidase flexibility and M. tuberculosis virulenceNIAID · 2026–2029 · via NIH RePORTERR01AI196228-01
- KPDeterminants of TB control, relapse and reinfection - Foreign Funding SupplementNational Institute of Allergy and Infectious Diseases · 2021–2026· 2 renewals
Completed grants (7)
- MPIRP-4: Immunologic Predictors of BCG Immunotherapy for Bladder CancerNCI · 2018–2025 · via NIH RePORTERP50CA221745-05
- PIRip1 controlled stress resistance and virulence in Mycobacterium tuberculosisNIAID · 2019–2024 · via NIH RePORTERR01AI138446-05
- MPIBiomarkers of PZA activity and it's target populationsNIAID · 2014–2021 · via NIH RePORTERU19AI111143-07
- PICD4 T Cell Responses to M. Tuberculosis InfectionNIAID · 2009–2015 · via NIH RePORTERR01AI080619-05
- PICyclopropane Synthetases and M.tuberculosis PathogenesisNIAID · 2003–2014 · via NIH RePORTERR01AI053417-10
- PIMolecular Analysis of the Rip1 Virulence Pathway of M. tuberculosisNIAID · 2009–2012 · via NIH RePORTERR01AI080628-02
Honors & distinctions
1 honor
- Damon Runyon Fellowship / Grant · Damon Runyon Cancer Research Foundation · 1995
News mentions
2 mentionsView all WCM news ↗
- New Insights into Bladder Cancer Treatment Could Help Improve ImmunotherapiesMay 29, 2025
Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center are expanding the understanding of how the BCG treatment for early bladder cancer works.
- $5 Million NIH Center Grant Will Support Next Generation TB ResearchSeptember 7, 2022
Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.
Mentoring
6 menteesAll publications with mentees →
- AKAdam KrebsImmunology & Microbial Pathogenesis (PhD) · Class of 2024
- AAAnthony AntonelliImmunology & Microbial Pathogenesis (PhD) · Class of 2021
- OAOyindamola AdefisayoImmunology & Microbial Pathogenesis (PhD) · Class of 2021
- HBHitesh BhattaraiMolecular Biology (PhD) · Class of 2015
- SKShireen KhayatPharmacology (PhD)
- EBEmilee BarnardMolecular Biology (PhD)
External relationships
Ownership
Vedanta Biosciences
Advisory/Scientific Board Member
Burroughs Wellcome Fund · Institute for Research in Biomedicine Barcelona · Vedanta Biosciences